Correlation Between Ameriprise Financial and Telix Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ameriprise Financial and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ameriprise Financial and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ameriprise Financial and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Ameriprise Financial and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ameriprise Financial with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ameriprise Financial and Telix Pharmaceuticals.

Diversification Opportunities for Ameriprise Financial and Telix Pharmaceuticals

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Ameriprise and Telix is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Ameriprise Financial and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Ameriprise Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ameriprise Financial are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Ameriprise Financial i.e., Ameriprise Financial and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ameriprise Financial and Telix Pharmaceuticals

Considering the 90-day investment horizon Ameriprise Financial is expected to under-perform the Telix Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ameriprise Financial is 2.32 times less risky than Telix Pharmaceuticals. The stock trades about -0.32 of its potential returns per unit of risk. The Telix Pharmaceuticals Limited is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  1,470  in Telix Pharmaceuticals Limited on September 23, 2024 and sell it today you would earn a total of  112.00  from holding Telix Pharmaceuticals Limited or generate 7.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ameriprise Financial  vs.  Telix Pharmaceuticals Limited

 Performance 
       Timeline  
Ameriprise Financial 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ameriprise Financial are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent primary indicators, Ameriprise Financial reported solid returns over the last few months and may actually be approaching a breakup point.
Telix Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Telix Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Ameriprise Financial and Telix Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ameriprise Financial and Telix Pharmaceuticals

The main advantage of trading using opposite Ameriprise Financial and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ameriprise Financial position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.
The idea behind Ameriprise Financial and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data